Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation

Overview of attention for article published in PharmacoEconomics, April 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

policy: 3 policy sources

twitter: 4 X users

Readers on

mendeley: 116 Mendeley

Summary Policy documents X

So far, Altmetric has seen 3 policy documents that reference this research output.

Atrial fibrillation: diagnosis and management : G1: Anticoagulant therapy for stroke prevention in people with atrial fibrillation

Cited by National Institute for Health and Care Excellence on 22 Apr 2021

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Patent Foramen Ovale lukking, platehemming eller antikoagulasjon for oppfølging av kryptogent hjerneslag

Cited by Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) on 22 Mar 2019

SBU is an independent national authority, tasked by the government with assessing health care and social service interventions from a broad perspective, covering medical, economic, ethical and social aspects.

CVD ROI tool: technical appendix

Cited by UK Government (GOV.UK) on 19 Oct 2018

GOV.UK is a central website that covers all UK government departments, as well as many other agencies and public bodies. All policy papers and research publications by the UK government are listed on GOV.UK.